A bloodstream infection (BSI) is a severe ICU-acquired infection. A growing proportion is
caused by multidrug-resistant bacteria (MDRB). COVID-19 was reported to be associated …

Two mutually related pandemics are ongoing worldwide: the COVID-19 and antimicrobial
resistance pandemics. This study aims to evaluate the impact of COVID-19 on multi-drug …

Purpose Patients presenting the most severe form of coronavirus disease 2019 (COVID-19)
pneumonia, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

A large proportion of ICU-acquired infections are related to multidrug-resistant bacteria
(MDR). Infections caused by these bacteria are associated with increased mortality, and …

Whether the risk of multidrug-resistant bacteria (MDRB) acquisition in the intensive care unit
(ICU) is modified by the COVID-19 crisis is unknown. In this single center case control study …

Purpose SARS-COV-2 pandemic led to antibiotic overprescription and unprecedented
stress on healthcare systems worldwide. Knowing the comparative incident risk of …

Background: The aim of this study was to assess the drivers of multidrug-resistant (MDR)
bacterial infection development in coronavirus disease 2019 (COVID-19) and its impact on …

Introduction We evaluated the prevalence, aetiologies and antibiotic resistance patterns of
bacterial infections in hospitalized patients with laboratory-confirmed SARS-CoV-2. We also …

HIGHLIGHTS Critically ill patients with COVID-19 can have secondary infections. Some of
them are caused by Multidrug-Resistant (MDR) Gram-Negative Bacteria (GNB). To know the …

Background We investigated the clinical characteristics and risk factors for the isolation of
multi-drug-resistant (MDR) Gram-negative bacteria (GNB) from critically ill COVID-19 …